Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

4 Randy Schekman - This 2013 Nobel Laureate Says College Is Way Too Expensive

4 Randy Schekman - This 2013 Nobel Laureate Says College Is Way Too Expensive

FromInquiring Minds


4 Randy Schekman - This 2013 Nobel Laureate Says College Is Way Too Expensive

FromInquiring Minds

ratings:
Length:
48 minutes
Released:
Oct 11, 2013
Format:
Podcast episode

Description

This week we talk to Randy Schekman, the University of California-Berkeley cell biologist who was just awarded the 2013 Nobel Prize in medicine for his work on how cells regulate the protein “traffic” that is at the core of their communication with other cells.
In the interview with co-host Indre Viskontas, Schekman not only explains his scientific breakthroughs—he also tells us why he wants to take a stand about the steeply rising cost of public higher education, which is driving huge student debt loads and rendering college simply too expensive for some. Affordable higher education, says Schekman, is “really in peril all over the country."
In addition to being a Nobel laureate, Schekman is also a winner of the coveted Albert Lasker Award for Basic Medical Research, a member of the National Academy of Sciences, and the former editor-in-chief of the Proceedings of the National Academy of Sciences.
This episode also features a (spoiler free) discussion of the science behind the hit sci-fi movie Gravity, and the controversy this year over the Nobel Prize in physics.
Subscribe:
itunes.apple.com/us/podcast/inquiring-minds/id711675943
feeds.feedburner.com/inquiring-minds
Released:
Oct 11, 2013
Format:
Podcast episode

Titles in the series (100)

Each week Inquiring Minds brings you a new, in-depth exploration of the space where science, politics, and society collide.We’re committed to the idea that making an effort to understand the world around you though science and critical thinking can benefit everyone—and lead to better decisions. We endeavor to find out what’s true, what’s left to discover, and why it all matters with weekly coverage of the latest headlines and probing discussions with leading scientists and thinkers.